Trump officials suppressed FDA vaccine studies with proven benefits

Federal health agencies under former President Donald Trump’s administration repeatedly blocked the release of vaccine safety studies, according to multiple reports this spring. The suppression efforts targeted research that contradicted anti-vaccine narratives promoted by then-Health Secretary Robert F. Kennedy Jr., undermining public confidence in proven medical interventions.

Agencies blocked publication of credible vaccine research

The New York Times confirmed on May 5 that the Food and Drug Administration (FDA) prevented agency scientists from publishing two studies on COVID-19 vaccines. Both manuscripts had been accepted for publication in medical journals, but unnamed FDA officials instructed the researchers to withdraw the papers. One study’s full manuscript, obtained by the Times, concluded that "given the available evidence, FDA continues to conclude the benefits of vaccination outweigh the risks."

Meanwhile, the Washington Post reported in April that the Centers for Disease Control and Prevention (CDC) scrapped a peer-reviewed study that found COVID-19 vaccines significantly reduced emergency care visits and hospitalizations among healthy adults. The study had been scheduled for publication in the CDC’s Morbidity and Mortality Weekly Report (MMWR) before the acting CDC director rejected it, citing concerns about methodology—a claim that drew criticism from public health experts.

Political interference overshadows scientific consensus

The incidents reflect a broader pattern of political interference in public health research during the Trump administration. Kennedy, who served as Health Secretary, had pledged "radical transparency" upon taking office but oversaw agencies that repeatedly censored findings contradicting his anti-vaccine stance. The suppressed studies focused on vaccines for COVID-19 and shingles, both of which underwent rigorous clinical trials and regulatory review before receiving approval.

Critics argue the actions politicized science, creating unnecessary doubt about vaccine safety at a time when misinformation was already eroding public trust. The CDC’s scrapped study, for example, was designed to evaluate real-world vaccine effectiveness, a critical metric for guiding policy decisions. By blocking its publication, officials deprived health professionals and policymakers of data that could have informed response strategies.

Broader implications for public health and trust

The revelations raise questions about the integrity of federal health agencies and their commitment to evidence-based policymaking. Vaccine hesitancy, already a persistent challenge, has been exacerbated by inconsistent messaging and the suppression of credible research. Public health experts warn that such interference undermines long-standing trust in institutions like the FDA and CDC, which rely on transparency to maintain credibility.

Looking ahead, the incidents underscore the need for safeguards against political influence in scientific research. As the world continues to navigate vaccine-related challenges, ensuring that studies are published regardless of their conclusions is essential for maintaining public confidence and guiding effective health policies.